TaiwanJ Pharmaceuticals Co., Ltd.(TW:6549)
NT$6.250.00 (0.00%)
TW:6549
TaiwanJ Pharmaceuticals Co., Ltd. financials statements
NT$6.25
At close:0.00 (0.00%)
TaiwanJ Pharmaceuticals Co., Ltd. (6549) Ratios
TaiwanJ Pharmaceuticals Co., Ltd. Ratios
TW:6549's free cash flow for Q2 2026 was NT$-7.10M. For the 2026 fiscal year, TW:6549's free cash flow was increased by NT$0.00 and operating cash flow was NT$-7.10M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 13.81 | 16.31 | 10.43 | 10.15 | 12.90 |
| Quick Ratio | 13.81 | 16.31 | 10.43 | 10.12 | 12.90 |
| Cash Ratio | 12.76 | 8.33 | 9.57 | 8.65 | 12.10 |
| Solvency Ratio | -3.59 | -3.58 | -0.61 | -1.96 | -1.64 |
| Operating Cash Flow Ratio | -4.24 | -3.96 | -0.13 | -3.00 | -1.47 |
| Short-Term Operating Cash Flow Coverage | -28.93 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 67.10M | NT$ 87.47M | NT$ 57.47M | NT$ 62.99M | NT$ 81.54M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 |
| Debt-to-Equity Ratio | 0.03 | 0.00 | 0.02 | 0.03 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.00 | 0.02 | 0.03 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.06 | 1.10 | 1.11 | 1.04 |
| Debt Service Coverage Ratio | -28.41 | -1572.23 | -167.13 | -1599.20 | -865.54 |
| Interest Coverage Ratio | -484.85 | -2073.54 | -275.42 | -9639.40 | -748.08 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.02 | 0.02 | 0.00 |
| Net Debt to EBITDA | 2.80 | 2.31 | 33.19 | 3.68 | 9.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 100.00% | -390.24% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | -16.48% | -602.13% | -46.71% |
| EBITDA Margin | 0.00% | 0.00% | -7.64% | -104.15% | -41.47% |
| Operating Profit Margin | 0.00% | 0.00% | -29.07% | -627.77% | -44.09% |
| Pretax Profit Margin | 0.00% | 0.00% | -16.59% | -602.19% | -46.77% |
| Net Profit Margin | 0.00% | 0.00% | -26.59% | -602.19% | -56.32% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -26.59% | -602.19% | -56.32% |
| Net Income Per EBT | 100.00% | 100.00% | 160.27% | 100.00% | 120.42% |
| EBT Per EBIT | 96.55% | 82.88% | 57.08% | 95.93% | 106.07% |
| Return on Assets (ROA) | -31.51% | -22.17% | -8.22% | -115.89% | -7.29% |
| Return on Equity (ROE) | -34.32% | -23.50% | -9.03% | -129.14% | -7.60% |
| Return on Capital Employed (ROCE) | -35.05% | -28.36% | -9.81% | -132.46% | -5.95% |
| Return on Invested Capital (ROIC) | -34.67% | -28.22% | -9.70% | -131.22% | -5.94% |
| Return on Tangible Assets | -31.51% | -22.17% | -8.26% | -117.27% | -13.28% |
| Earnings Yield | -3.94% | -3.56% | -0.54% | -11.67% | -1.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 79.52 | 3.33 | 4.19 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 406.90 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 7.49 | 5.07 | 68.07 |
| Asset Turnover | 0.00 | 0.00 | 0.31 | 0.19 | 0.13 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.37 | 0.21 | 0.25 |
| Cash Conversion Cycle | 0.00 | 0.00 | 4.59 | 110.41 | 87.05 |
| Days of Sales Outstanding | 0.00 | 0.00 | 4.59 | 109.51 | 87.05 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.90 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 4.59 | 110.41 | 87.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.28 | -0.30 | -0.01 | -0.28 | -0.13 |
| Free Cash Flow Per Share | -0.28 | -0.30 | -0.03 | -0.30 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | -78.80 | 0.00 | -0.57 | -17.20 | 0.00 |
| Capital Expenditure Coverage Ratio | -78.80 | 0.00 | -0.57 | -17.20 | 0.00 |
| Operating Cash Flow Coverage Ratio | -12.60 | -47.93 | -0.70 | -11.34 | -30.36 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -0.04 | -1.37 | -0.46 |
| Free Cash Flow Yield | -3.69% | -3.60% | -0.20% | -2.81% | -1.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -25.70 | -28.28 | -183.50 | -8.58 | -62.81 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 48.79 | 51.61 | 34.22 |
| Price-to-Book (P/B) Ratio | 8.71 | 6.60 | 16.58 | 11.07 | 4.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -27.07 | -27.75 | -490.55 | -35.54 | -75.12 |
| Price-to-Operating Cash Flow Ratio | -27.41 | -27.75 | -1351.55 | -37.61 | -75.12 |
| Price-to-Earnings Growth (PEG) Ratio | -7.45 | -0.11 | 1.96 | -0.01 | 0.86 |
| Enterprise Value Multiple | -23.37 | -28.40 | -605.62 | -45.88 | -73.50 |
| Enterprise Value | 551.70M | 580.52M | 1.05B | 733.71M | 672.22M |
| EV to EBITDA | -23.37 | -28.40 | -605.62 | -45.88 | -73.50 |
| EV to Sales | 0.00 | 0.00 | 46.26 | 47.78 | 30.48 |
| EV to Free Cash Flow | -24.17 | -25.66 | -465.06 | -32.90 | -66.90 |
| EV to Operating Cash Flow | -24.48 | -25.66 | -1281.32 | -34.82 | -66.90 |
| Tangible Book Value Per Share | 0.89 | 1.24 | 0.88 | 0.94 | 1.15 |
| Shareholders’ Equity Per Share | 0.89 | 1.24 | 0.89 | 0.95 | 2.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.60 | 0.00 | -0.20 |
| Revenue Per Share | 0.00 | 0.00 | 0.30 | 0.20 | 0.29 |
| Net Income Per Share | -0.30 | -0.29 | -0.08 | -1.23 | -0.17 |
| Tax Burden | 1.00 | 1.00 | 1.60 | 1.00 | 1.20 |
| Interest Burden | 0.97 | 1.00 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.61 | 0.83 | 0.80 |
| SG&A to Revenue | 0.00 | 0.00 | 0.68 | 0.85 | 0.64 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.06 | 0.04 | -0.00 |
| Income Quality | 0.93 | 1.01 | 0.14 | 0.23 | 0.81 |
Currency in TWD
